Log in
Request a free trial
Request a free trial
Log in
Products
Solutions
Data
News & Analysis
About
Blog
News & Analysis
driven by the PitchBook Platform
Articles
reports
All articles
All
Venture Capital
Private Equity
M&A
Tech
Europe
reports
Subscribe
New Investor Trio Leads $12M Series B Financing for Coferon
July 18, 2012
Share:
New York-based biotechnology company
Coferon
has closed on $12 million of Series B financing led by new investors
Hatteras Venture Partners
,
MedImmune Ventures
and
Ascent Biomedical Ventures
. Currently, Coferon is conducting research and development of epignetics and anti-infectives.
Coferon
Drug Discovery
Stony Brook, NY
$12 million
Series B
View details
Lead Investors
Ascent Biomedical Ventures
Hatteras Venture Partners
MedImmune Ventures
Share:
Tags:
Private Equity,
Venture Capital
Related content
Load more